Epothilone derivative for the treatment of hepatoma and other cancer diseases

摘要

Disclosed is a use of an epothilone derivative of formula (I) in the manufacture of a medicament for the treatment of a cancer disease selected from hepatoma; primary fallopian tube cancer; primary peritoneal cancer; renal cell carcinoma progressing after treatment with a cytokine; radiotherapy and/or nephrectomy; ovarian cancer progressing after treatment with a platinum compound or radiotherapy; and colorectal cancer progressing after radiotherapy and/or treatment with oxaliplatin or irinotecan; and metastasis thereof.